Kosenko, T., Golder, M., Leblond, G., Weng, W., & Lagace, T. A. (2013). Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation. American Society for Biochemistry and Molecular Biology.
Citação norma ChicagoKosenko, Tanja, Mia Golder, Geoffrey Leblond, Willy Weng, and Thomas A. Lagace. Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation. American Society for Biochemistry and Molecular Biology, 2013.
Citação norma MLAKosenko, Tanja, et al. Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation. American Society for Biochemistry and Molecular Biology, 2013.